FDA Okays Varian Medical's Latest Release Of Eclipse Treatment Planning Software

(RTTNews) - Varian Medical Systems (VAR) said it has received 510(k) clearance from the U.S. Food and Drug Administration for the latest release of the company's Eclipse treatment planning software.

This software now incorporates the Acuros PT advanced dose calculation algorithm for faster, more accurate proton therapy treatment planning.

Other enhancements to the Eclipse software include robust planning and optimization tools. The latest release also enables users to create scripts that expedite planning functions, quality assurance, data mining, and research.

The Acuros PT dose calculation algorithm is designed to improve the accuracy of the proton dose calculation, especially in regions of the body where the tissues vary in density such as the lung, where air, bone, and soft tissue are in close proximity.

Proton planning in Eclipse using the Acuros PT algorithm takes significantly less time than was previously required using other methods, Varian Medical said.